GPT and skin infection: Overall, six serious adverse events (SAEs) occurred during the trial among four subjects (one on the continuous arm (Arm 1), three on the intermittent arm (Arm 2): lymphocytopenia, elevated alanine aminotransferase, elevated aspartate aminotransferase, skin infection, soft tissue infection, and obstruction of the small intestine.